|
🐜
|
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
47 auth.
A. Tyndall,
B. Bannert,
M. Vonk,
P. Airó,
F. Cozzi,
P. Carreira,
D. F. Bancel,
Y. Allanore,
U. Müller-Ladner,
O. Distler,
F. Iannone,
R. Pellerito,
M. Pileckytė,
I. Miniati,
L. Ananieva,
...
A. B. Gurman,
N. Damjanov,
Adelheid Mueller,
G. Valentini,
G. Riemekasten,
M. Tikly,
L. Hummers,
M. J. Henriques,
P. Caramaschi,
A. Scheja,
B. Rozman,
E. Ton,
G. Kumánovics,
B. Coleiro,
E. Feierl,
G. Szűcs,
C. V. von Mühlen,
V. Riccieri,
S. Novak,
C. Chizzolini,
A. Kotulska,
C. Denton,
P. Coelho,
I. Kötter,
I. Simsek,
Paloma García de la Peña Lefebvre,
E. Hachulla,
J. Seibold,
S. Rednic,
J. Štork,
J. Morović-Vergles,
U. Walker
|
10 |
2010 |
10
🐜
|
|
🐜
|
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
15 auth.
B. Bresnihan,
J. Álvaro-Gracia,
M. Cobby,
M. Doherty,
Z. Domljan,
P. Emery,
G. Nuki,
K. Pavelka,
R. Rau,
B. Rozman,
...
I. Watt,
B. Williams,
R. Aitchison,
D. McCabe,
P. Musikic
|
10 |
1998 |
10
🐜
|
|
🐜
|
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
9 auth.
J. Smolen,
J. Kalden,
D. Scott,
B. Rozman,
T. Kvien,
A. Larsen,
...
I. Loew-Friedrich,
C. Oed,
R. Rosenburg
|
9 |
1999 |
9
🐜
|
|
🐬
|
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
A. Kužnik,
M. Benčina,
U. Švajger,
M. Jeras,
B. Rozman,
R. Jerala
|
9 |
2011 |
9
🐬
|
|
🐜
|
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
128 auth.
J. Avouac,
J. Fransen,
U. Walker,
V. Riccieri,
V. Smith,
C. Müller,
I. Miniati,
I. Tarner,
S. B. Randone,
M. Cutolo,
Y. Allanore,
O. Distler,
G. Valentini,
L. Czirják,
U. Müller-Ladner,
...
D. Furst,
A. Tyndall,
M. Matucci-Cerinic,
F. Keyser,
A. Sulli,
C. Pizzorni,
B. Maurer,
Stanislaw Sierakowsky,
O. Kowal-Bielecka,
P. Coelho,
G. Riemekasten,
S. Rednic,
Ileana Nicoara,
R. Caporali,
J. Štork,
M. Inanç,
P. Carreira,
S. Novak,
C. Varjú,
C. Chizzolini,
C. Ribi,
E. Kucharz,
A. Kotulska,
M. Widuchowska,
J. Richter,
A. Sipek-Dolnicar,
B. Rozman,
A. Gabrielli,
G. Moroncini,
D. Farge,
C. Durant,
H. Kiener,
E. Rath,
P. Airò,
F. Wollheim,
N. Hunzelmann,
S. Bombardieri,
A. D. Rossa,
L. Bazzichi,
R. Pellerito,
M. Saracco,
C. Denton,
M. Vonk,
F. Hoogen,
N. Damjanov,
I. Kötter,
S. Heitmann,
M. Seidel,
P. Hasler,
J. V. Laar,
M. J. Salvador,
J. P. D. Silva,
S. Jacobsen,
M. Worm,
Annegret Kuhn,
T. Nevskaya,
Nasonov El,
R. Scorza,
H. Nielsen,
R. Silver,
E. Hachulla,
D. Launay,
G. Valesini,
R. Ionescu,
D. Opris,
N. Papa,
W. Maglione,
D. Comina,
G. Udrea,
Coziana Ciurtin,
R. Ioniţescu,
C. Mihai,
C. Sunderkötter,
Jae-Bum Jun,
C. Derk,
S. Alhasani,
L. Alhajjar,
E. Ton,
J. Seibold,
P. Nash,
L. Mouthon,
C. V. Mühlen,
B. Krummel-Lorenz,
P. Eilbacher,
R. Westhovens,
E. Langhe,
M. Mayer,
B. Anić,
M. Barešić,
F. Stoeckl,
Maria Uprus,
S. Popa,
M. Buslau,
B. Granel,
T. Zénone,
A. Mathieu,
A. Vacca,
P. Amerio,
T. Tourinho,
L. Lonzetti,
M. L. Lopes,
R. Souza,
D. Vealex,
P. Caramaschi,
A. Balbir-Gurman,
Y. Braun,
S. Ullman,
M. Szmyrka-Kaczmarek,
E. Morgiel,
M. Vanthuyne,
M. Meurer,
P. Rehberger,
P. Sampaio-Barros
|
8 |
2010 |
8
🐜
|
|
🐜
|
The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study
15 auth.
B. Laat,
V. Pengo,
I. Pabinger,
J. Musial,
A. Voskuyl,
I. Bultink,
A. Ruffatti,
B. Rozman,
T. Kveder,
P. Moerloose,
...
F. Boehlen,
J. Rand,
Z. Ulčová-Gallová,
K. Mertens,
P. G. D. Groot
|
8 |
2009 |
8
🐜
|
|
🐜
|
Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis
15 auth.
V. Mladenovic,
Z. Domljan,
B. Rozman,
I. Jajić,
D. Mihajlović,
J. Dordević,
M. Popovic,
M. Dimitrijević,
M. Zivkovic,
G. Campion,
...
P. Musikic,
I. Löw-Friedrich,
C. Oed,
H. Seifert,
V. Strand
|
8 |
1995 |
8
🐜
|
|
🦁
|
Clinical Pharmacokinetics of Leflunomide
B. Rozman
|
7 |
2002 |
7
🦁
|
|
🐜
|
Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry
16 auth.
T. Avčin,
R. Cimaz,
E. Silverman,
R. Cervera,
M. Gattorno,
S. Garay,
Y. Berkun,
F. Sztajnbok,
C. Silva,
L. Campos,
...
C. Saad-Magalhães,
D. Rigante,
A. Ravelli,
A. Martini,
B. Rozman,
P. Meroni
|
7 |
2008 |
7
🐜
|
|
🐬
|
Ultrasonographic changes of major salivary glands in primary Sjogren's syndrome. Diagnostic value of a novel scoring system.
A. Hočevar,
A. Ambrožič,
B. Rozman,
T. Kveder,
M. Tomšič
|
7 |
2005 |
7
🐬
|
|
🐜
|
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
9 auth.
J. Smolen,
J. Kalden,
D. Scott,
B. Rozman,
T. Kvien,
A. Larsen,
...
I. Loew-Friedrich,
C. Oed,
R. Rosenburg
|
7 |
1999 |
7
🐜
|
|
🐬
|
Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging
V. Jevtič,
I. Watt,
B. Rozman,
M. Kos-Golja,
F. Demsar,
O. Jarh
|
7 |
1995 |
7
🐬
|
